CMKLR1 antagonist 1 |
| Catalog No.GC71381 |
CMKLR1 antagonist 1 (composé S - 26d) est un antagoniste puissant et actif par voie orale du récepteur de type Chimiokine 1 (cmklr1) avec une pic 50 de 7,44 dans les cellules Cho transfectées par hcmklr1.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 3033101-08-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
CMKLR1 antagonist 1 (compound S-26d) is a potent and orally active chemokine-like receptor 1 (CMKLR1) antagonist, with a pIC50 value of 7.44 in hCMKLR1-transfected CHO cells. CMKLR1 antagonist 1 can be used for psoriasis and metabolic diseases research.
References:
[1]. Ko B, et al. Discovery of 3-Phenyl Indazole-Based Novel Chemokine-like Receptor 1 Antagonists for the Treatment of Psoriasis. J Med Chem. 2023 Oct 26.
Review for CMKLR1 antagonist 1
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for CMKLR1 antagonist 1
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *